Seelos Therapeutics Inc (SEEL): Presentation today announced that Richa...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Seelos Therapeutics Inc (SEEL)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	5
Posts	289
Boards Moderated	0
Alias Born	08/15/2013

Re: None

Tuesday, 02/02/2016 9:12:27 AM

Tuesday, February 02, 2016 9:12:27 AM

Presentation
today announced that Richard Pascoe, Chief Executive Officer, will present at the 18th Annual BIO CEO & Investor Conference on Monday, February 8, 2016, at 9:30 a.m. Eastern Time. The conference will be held at The Waldorf Astoria, New York, NY. Mr. Pascoe will provide an update on Vitaros®, the Company's topical treatment for erectile dysfunction, as well as Apricus' drug candidates fispemifene, for the treatment of men with secondary hypogonadism and RayVa™, for the treatment of patients with Raynaud's phenomenon.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SEEL News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 01:00:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 03:45:26 PM

More SEEL News

InvestorsHub NewsWire

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM

Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM

ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM

Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow